Skip to main content

UNITED WE CURE.

We’re Changing How Science Is Done Because Kids Can’t Wait

CBTN doesn’t wait for change—we drive it, turning global collaboration into faster discovery and better futures for children.

RESEARCH COMMUNITYFAMILIES & FOUNDATIONS

UNITED WE CURE.

We’re Changing How Science Is Done Because Kids Can’t Wait

CBTN doesn’t wait for change—we drive it. Through a global network of scientists, clinicians, and advocates, we accelerate discovery, dismantle barriers, and deliver better outcomes, because every child deserves a future filled with possibility.

RESEARCH COMMUNITYFAMILIES & FOUNDATIONS

MAKING THE IMPOSSIBLE POSSIBLE

Powered by the world’s most extensive collection of pediatric brain tumor biosamples, medical data, imaging, and preclinical models, CBTN breaks down research barriers and fuels global collaboration. With research hospitals contributing from every corner of the world and passionate family foundations standing behind our mission, we accelerate the discoveries that will change everything for children.

8,000

patient & family participants

9

countries represented

35

member institutions

24

family foundations

85,000

biosamples

1,000

investigators

442+

research projects

220+

scientific publications

CBTN Collaboration Reveals Potential Treatment Targets for High-Grade Glioma

CBTN Collaboration Reveals Potential Treatment Targets for High-Grade Glioma

Tumor samples collected through the Children’s Brain Tumor Network (CBTN) helped power a collaborative study identifying potential treatment targets and markers associated with outcomes in children, adolescents, and young adults with high-grade glioma. Published in Cell Reports Medicine, the Mount Sinai-led study brought together CBTN, the National Cancer Institute’s Clinical…
Read More
New NIH Grant Uses CBTN Data to Pursue Pediatric Treatment Targets

New NIH Grant Uses CBTN Data to Pursue Pediatric Treatment Targets

Pediatric low-grade glioma (pLGG) is the most common childhood brain tumor, but it doesn’t affect every child in the same way. Some tumors remain stable for years, while others grow, return, or don’t respond to treatment as expected. Even tumors that look alike or share the same DNA changes may…
Read More
Dr. Sarah Leary Appointed Co-Chair of Children’s Brain Tumor Network Executive Board

Dr. Sarah Leary Appointed Co-Chair of Children’s Brain Tumor Network Executive Board

Originally released on PRNewswire on September 22, 2026. National pediatric brain tumor leader to help guide CBTN’s evolution toward a continuously learning health system The Children’s Brain Tumor Network (CBTN) has appointed Sarah Leary, MD, MS, as Co-Chair of its Executive Board. Serving alongside Brian Rood, MD, she will help…
Read More